Shore Capital reiterated their not rated rating on shares of Genus (LON:GNS – Free Report) in a research report sent to investors on Friday, Marketbeat.com reports.
Genus Stock Performance
GNS opened at GBX 1,680 ($21.10) on Friday. The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.54. The company’s fifty day moving average price is GBX 1,949.67 and its two-hundred day moving average price is GBX 1,835.82. Genus has a 1-year low of GBX 1,478 ($18.56) and a 1-year high of GBX 2,378 ($29.87). The company has a market cap of £1.10 billion, a price-to-earnings ratio of 14,000.00, a PEG ratio of 2.87 and a beta of 0.37.
Genus Increases Dividend
The firm also recently disclosed a dividend, which will be paid on Friday, December 6th. Shareholders of record on Thursday, November 7th will be issued a dividend of GBX 21.70 ($0.27) per share. This is an increase from Genus’s previous dividend of $10.30. The ex-dividend date of this dividend is Thursday, November 7th. This represents a yield of 1.21%. Genus’s dividend payout ratio is presently 26,666.67%.
Insider Transactions at Genus
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Further Reading
- Five stocks we like better than Genus
- The 3 Best Blue-Chip Stocks to Buy Now
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- Where Do I Find 52-Week Highs and Lows?
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.